Ask AI

Integrating Bispecific Antibody Therapy for Multiple Myeloma Into Your Community Practice: Case Studies and Expert Guidance

The downloadable slideset illustrates the principles needed to establish workflows that are required for community centers to fully integrate BsAb therapy into their patient care. Preparation and resources are needed to identify eligible patients and safely administer BsAb therapy. Education is necessary for healthcare professionals to understand how to manage the adverse effects possible with BsAbs, and pharmacies are required to establish a REMS program. 

BsAb In Community

Activity Information

Released: August 31, 2026